C12N 2740/10045
Special targeting system for viral vectors
C12N2740/10045 (Special targeting system for viral vectors) appears on 7 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 18
- Assignees
- 15
- Inventors
- 38
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 2 | 3 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
| 2025 | 2 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Adapter-based retroviral vector system for the selective transduction of target cells22 Jul 2025US 12,365,916 B2Miltenyi Biotec GmbH
- Methods and compositions for transducing lymphocytes and regulating the activity thereof25 Mar 2025US 12,258,574 B2Exuma Biotech Corp.
- CD62L specific lentiviral vector particle for targeted transduction of T cell subsets25 Jun 2024US 12,018,273 B2Miltenyi Biorec B V. Co., KG
- Methods and compositions for transducing lymphocytes and regulating the activity thereof7 Sep 2021US 11,111,505 B2Exuma Biotech Corp.
- Retroviral vector with mini-promoter cassette20 Jul 2021US 11,065,311 B2Denovo Biopharma LLC
- Adapter-based retroviral vector system for the selective transduction of target cells7 May 2026US 2026/0125703 A1Miltenyi Biotec GmbH
- Anti-cd90 antibodies, binding fragments, and uses thereof7 Aug 2025US 2025/0249125 A1Fred Hutchison Cancer Center
- Methods and compositions for transducing lymphocytes and regulating the activity thereof24 Jul 2025US 2025/0236889 A1Exuma Biotech Corp.
- Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses8 May 2025US 2025/0144235 A1Sana Biotechnology, Inc.
- Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules13 Jun 2024US 2024/0189247 A1
Most cited
By later US patents
- Methods and compositions for transducing lymphocytes and regulating the activity thereof3US 11,111,505 B2Exuma Biotech Corp. · 2021
- Methods and compositions for transducing lymphocytes and regulating the activity thereof1US 12,258,574 B2Exuma Biotech Corp. · 2025
- Targeting pseudotyped retroviral vectors1US 8,449,875 B2The Regents of the University of California · 2013
- Targeting pseudotyped retroviral vectors1US 9,163,248 B2The Regents of the University of California · 2015